| 2CKO |
2.15 |
Crystal structure of Human Choline Kinase alpha 2 |
| 2CKP |
3.1 |
Crystal structure of Human Choline Kinase alpha-2 in complex with ADP |
| 2CKQ |
2.4 |
Crystal structure of Human Choline Kinase alpha 2 in complex with Phosphocholine |
| 2I7Q |
1.9 |
Crystal structure of Human Choline Kinase A |
| 3F2R |
2.35 |
Crystal structure of human choline kinase alpha in complex with hemicholinium-3 |
| 3G15 |
1.7 |
Crystal structure of human choline kinase alpha in complex with hemicholinium-3 and ADP |
| 3ZM9 |
1.9 |
The mechanism of allosteric coupling in choline kinase a1 revealed by a rationally designed inhibitor |
| 4BR3 |
2.2 |
Determination of potential scaffolds for human choline kinase alpha 1 by chemical deconvolution studies |
| 4CG8 |
1.75 |
Human choline kinase a1 in complex with compound 14 |
| 4CG9 |
1.83 |
Human choline kinase a1 in complex with compound 12 |
| 4CGA |
1.74 |
Human choline kinase a1 in complex with compound 5 |
| 4DA5 |
2.4 |
Choline Kinase alpha acts through a double-displacement kinetic mechanism involving enzyme isomerisation, as determined through enzyme and inhibitor kinetics and structural biology |
| 5AFV |
2.25 |
Pharmacophore-based virtual screening to discover new active compounds for human choline kinase alpha1. |
| 5EQE |
2.4 |
Crystal structure of choline kinase alpha-1 bound by [4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methanamine (compound 11) |
| 5EQP |
2.35 |
Crystal structure of choline kinase alpha-1 bound by 6-[(4-methyl-1,4-diazepan-1-yl)methyl]quinoline (compound 37) |
| 5EQY |
2.5 |
Crystal structure of choline kinase alpha-1 bound by 5-[(4-methyl-1,4-diazepan-1-yl)methyl]-2-[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]benzenecarbonitrile (compound 65) |
| 5FTG |
1.45 |
Human choline kinase a1 in complex with compound 1-[[4-[2-[4-[[4-(dimethylamino)pyridin-1- yl]methyl]phenoxy]ethoxy]phenyl]methyl]-N,N- dimethyl-pyridin-4-amine (compound 10a) |
| 5FUT |
1.6 |
Human choline kinase a1 in complex with compound 4-(dimethylamino)-1-{4-[4-(4-{[4-(pyrrolidin- 1-yl)pyridinium-1-yl]methyl}phenyl)butyl]benzyl}pyridinium (compound BR25) |
| 5W6O |
2.35 |
Choline Kinase Alpha in Complex with TCD-717 |
| 7A04 |
2.15 |
Structure of human CKa1 in complex with compound b |
| 7A06 |
1.8 |
Structure of human CKa1 in complex with compound o |
| 7NB1 |
2.3 |
Crystal structure of human choline alpha in complex with an inhibitor |
| 7NB2 |
2.4 |
Crystal structure of human choline alpha in complex with an inhibitor |
| 7NB3 |
2.0 |
Crystal structure of human choline alpha in complex with an inhibitor |
